期刊文献+

分子佐剂TBhsp和MT在肝细胞再生磷酸酶-3(PRL-3)单克隆抗体制备中的作用

Role of molecular adjuvants TBhsp and MT in the preparation of monoclonal antibody against phosphatase of regenerating liver-3
下载PDF
导出
摘要 目的探讨结核分枝杆菌热休克蛋白(TBhsp)和结核分枝杆菌T细胞刺激表位(MT)在肝细胞再生磷酸酶-3(PRL-3)单克隆抗体(mAb)制备过程中的佐剂作用。方法构建对照质粒pET28a-PRL-3和佐剂-PRL-3融合蛋白表达质粒pET28a-PRL-3-MT、pET28a-TBhsp-PRL-3和pET28a-TBhsp-PRL-3-MT,并纯化其表达蛋白,分别免疫BALB/c小鼠,ELISA检测并比较各组的抗血清效价,选取效价最高的小鼠,采用杂交瘤技术制备PRL-3 mAb,并进行类和亚类鉴定。结果成功构建了上述4种PRL-3相关的重组表达质粒,并表达纯化出相应的融合蛋白,其中PRL-3-MT融合蛋白免疫组抗体效价高于其他组;用该组小鼠进行细胞融合并筛选获得均为IgG类的10株分泌PRL-3 mAb的细胞株。结论 MT在PRL-3 mAb制备中可以发挥较为明显的免疫佐剂作用。 Objective To explore the adjuvant effects of Mycobacterium tuberculosis heat shock protein (TBhsp) and Mycobactedum tuberculosis T cell stimulatory epitope (MT) in the preparation of the monoclonal antibody (mAb) against phosphatase of regenerating liver-3 (PRL-3). Methods The prokaryotic expression vectors pET28a were used for the construction of pET28a-PRL-3 (control plasmids), pET28a-PRL-3-MT, pET28a-TBhsp-PRL-3 and pET28a- TBhsp-PRL-3-MT (recombinant plasmids). The various fusion proteins expressed in bacteria were purified and utilized to immunize the BALB/c mice, respectively. The serum level of specific anti-PRL-3 antibody was measured by ELISA. The mouse with the highest serum level of anti-PRL-3 antibody was selected to prepare mAb with hybridoma technique. The subclasses of mAb were identified. Results The PRL-3 fusion proteins expressed from the four expression plasmids were purified successfully. The serum level of anti-PRL-3 antibody from the mice immunized with PRL-3-MT was the highest compared with the other immune groups. Ten hybridoma cell lines secreting anti-PRL-3 mAb were obtained after cell fusion and ELISA primary screening, and all of the mAb subclasses were IgG. Conclusion MT is a potentially effective molecular adjuvant in preparation of mAb specific for PRL-3.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第6期614-617,626,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81071732)
关键词 肝细胞再生磷酸酶-3 结核分枝杆菌热休克蛋白 结核分枝杆菌T细胞刺激表位 phosphatase of regenerating liver-3 Mycobactefium tuberculosis heat shock protein Mycobacterium tuberculosisT cell stimulatory epitope
  • 相关文献

参考文献18

  • 1Xing X, Lian S, Hu Y, et al. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma[ J/OL]. J Transl Med, 2013, 11 ( 1 ) : 309.
  • 2Rios P, Li X, Kfhn M. Molecular mechanisms of the PRL phosphatases [J]. FEBS J, 2013, 280 (2) : 505 -524.
  • 3Peng L, Xing X, Li W, et al. PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin betal-ERK1/2 and-MMP2 signaling[ J/OL]. Mol Cancer, 2009, 8: 110.
  • 4Guzika-Ustymowicz K, Kiluk J, Tertikowski SJ, et al. Expression of phosphatase of regenerating liver-3 ( PRL-3 ) in endometrioid cancer and lymph nodes metastases[ J/OA]. Adv Med Sei, 2013, 58(2): 221 - 226.
  • 5Peng L, Li Y, Meng L, et al. Preparation and characterization of monoelonal antibody against protein tyrosine phosphatase PRL-3 [ J ]. Hybrid Hybridomics, 2004, 23 ( 1 ) : 23 - 27.
  • 6Jiang J, Xie D, Zhang W, et al. Fusion of Hsp70 to Mage-al enhances the potency of vaccine-specific immune responses[ J/OL]. J Transl Med, 2013, 11 ( 1 ) : 300.
  • 7Romln E, MorenoC. Synthetic peptides non-covalently bound to bacterial hspT0 elicit peptide-specific T-cell responses in vivo [ J ]. Immunology, 1996, 88(4) : 487 -492.
  • 8Suzue K, Young RA. Adjuvant-free hspT0 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24 [ J ]. J Immunol, 1996, 156(2) : 873 -879.
  • 9Qian X, Lu Y, Liu Q, et al. Prophylactic, therapeutic and antimetastatie effects of an HPV-16mE6Delta/mE7/TBhsp70 Delta fusion protein vaccine in an animal model[J]. Immunol Lett, 2006, 102(2) : 191 - 201.
  • 10Zong J, Wang C, Wang Q, et al. HSP70 and modified HPV16 E7 fusion gene without the addition of a signal peptide gene sequence as a candidate therapeutic tumor vaccine [ J]. Oncol Rep, 2013, 30 (6) : 3020 - 3026.

二级参考文献50

  • 1何萍,吕凤林,陈月,李元朝,何凤慈.铝佐剂毫微粒的制备及其对小鼠T_H2细胞亚群影响的研究[J].中华微生物学和免疫学杂志,2005,25(4):301-301. 被引量:6
  • 2Clements DE,Coller BG,Lieberman MM,et al.Development of recombinant tetravalent dengue virus vaccine:immunogenicity and and efficacy studies in mice and monkeys[J].Vaccine,2010,28 (15):2705-2715.
  • 3Black M,Trent A,Tirrell M,et AL.Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists[J].Expert Rev Vaccines,2010,9(2):157-173.
  • 4Babu JP,Pattnaik P,Gupta N,et al.Immunogenicity of a recombinanl envelope domain Ⅲ protein of dengue virus typ-4 with various adjuvants in mice[J].Vaccine,2008,26(36):4655-4663.
  • 5Brunner R,Jensen-Jarolim E,Palli-SchollI.The ABC of clinical and experimental adjuvants-A brief overview[J].Immunol Lett,2010,128(1):29-35.
  • 6Aguilar JC,Rodrguez EG.Vaccine adjuvants revisited[J].Vaccine,2007,25 (19):3752-3762.
  • 7Petrovsky N,Aguilar JC.Vaccine adjuvants:current state and future trends[J].Immunol Cell Biol,2004,82(5):488-496.
  • 8Aucouturier J,Dupuis L,Deville S,et al.Montanide ISA 720 and 51:a new generation of water in oil emulsions as adjuvants for human vaccines[J].Exp Rev Vaccines,2002,1 (1):111-118.
  • 9Saul A,Lawrence G,Allworth A,et al.A human phase 1 vaccine clinical trial of the plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in montanide ISA720 adjuvant[J].Vaccine,2005,23(23):3076-3083.
  • 10Jiang ZX,Zhang ZY. Targeting PTPs with small molecule in- hibitors in cancer treatment. Cancer Metastasis Rev, 2008,27 ( 2 ) : 263-272.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部